150 related articles for article (PubMed ID: 10797262)
1. Loss of heterozygosity at chromosome segments 8p22 and 8p11.2-21.1 in transitional-cell carcinoma of the urinary bladder.
Choi C; Kim MH; Juhng SW; Oh BR
Int J Cancer; 2000 May; 86(4):501-5. PubMed ID: 10797262
[TBL] [Abstract][Full Text] [Related]
2. Deletion mapping implicates two tumor suppressor genes on chromosome 8p in the development of bladder cancer.
Takle LA; Knowles MA
Oncogene; 1996 Mar; 12(5):1083-7. PubMed ID: 8649800
[TBL] [Abstract][Full Text] [Related]
3. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
[TBL] [Abstract][Full Text] [Related]
4. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
5. Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22.
Ohgaki K; Iida A; Ogawa O; Kubota Y; Akimoto M; Emi M
Genes Chromosomes Cancer; 1999 May; 25(1):1-5. PubMed ID: 10221333
[TBL] [Abstract][Full Text] [Related]
6. High density deletion mapping of bladder cancer localizes the putative tumor suppressor gene between loci D8S504 and D8S264 at chromosome 8p23.3.
Muscheck M; Sükösd F; Pesti T; Kovacs G
Lab Invest; 2000 Jul; 80(7):1089-93. PubMed ID: 10908154
[TBL] [Abstract][Full Text] [Related]
7. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
8. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
9. Role of loss of heterozygosity on chromosomes 8 and 9 in the development and progression of cancer bladder.
Abdel Wahab AH; Abo-Zeid HI; El-Husseini MI; Ismail M; El-Khor AM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):260-9. PubMed ID: 17102820
[TBL] [Abstract][Full Text] [Related]
10. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
11. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.
Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA
Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331
[TBL] [Abstract][Full Text] [Related]
12. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
[TBL] [Abstract][Full Text] [Related]
13. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer.
Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA
Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456
[TBL] [Abstract][Full Text] [Related]
14. Definition and refinement of chromosome 8p regions of loss of heterozygosity in gastric cancer.
Baffa R; Santoro R; Bullrich F; Mandes B; Ishii H; Croce CM
Clin Cancer Res; 2000 Apr; 6(4):1372-7. PubMed ID: 10778965
[TBL] [Abstract][Full Text] [Related]
15. Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization.
Chan MW; Hui AB; Yip SK; Ng CF; Lo KW; Tong JH; Chan AW; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
Int J Oncol; 2009 Apr; 34(4):963-70. PubMed ID: 19287953
[TBL] [Abstract][Full Text] [Related]
16. Molecular serological diagnosis in transitional cell bladder cancer.
von Knobloch R; Brandt H; Hofmann R
Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
[TBL] [Abstract][Full Text] [Related]
17. High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder.
Natrajan R; Louhelainen J; Williams S; Laye J; Knowles MA
Cancer Res; 2003 Nov; 63(22):7657-62. PubMed ID: 14633686
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
[TBL] [Abstract][Full Text] [Related]
20. A case of transitional cell carcinoma of the bladder with a del(9)(q11q21.2).
Bernués M; Casadevall C; Miró R; Caballín MR; Gelabert A; Egozcue J
Cancer Genet Cytogenet; 1993 Aug; 69(1):76-7. PubMed ID: 8374907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
